共 142 条
[1]
Bouchardy C(2007)Older female cancer patients: importance, causes, and consequences of undertreatment J Clin Oncol. 25 1858-1869
[2]
Rapiti E(2012)Predictors of critical care-related complications in colectomy patients using the National Surgical Quality Improvement Program: exploring frailty and aggressive laparoscopic approaches J Trauma Acute Care Surg. 72 878-883
[3]
Blagojevic S(2012)Significance of age and comorbidity on treatment modality, treatment adherence, and prognosis in elderly ovarian cancer patients Gynecol Oncol. 127 367-374
[4]
Vlastos AT(2015)Long-term survival advantage and prognostic factors associated with intraperitoneal chemotherapy treatment in advanced ovarian cancer: a gynecologic oncology group study J Clin Oncol. 33 1460-1466
[5]
Vlastos G(2017)Consolidation hyperthermic intraperitoneal chemotherapy for the treatment of advanced stage ovarian carcinoma: a 3 year experience Cancer Chemother Pharmacol. 80 405-410
[6]
Obeid NM(2018)Hyperthermic intraperitoneal chemotherapy in ovarian cancer N Engl J Med. 378 230-240
[7]
Azuh O(2015)Cytoreductive surgery and HIPEC in recurrent epithelial ovarian cancer: a prospective randomized phase III study Ann Surg Oncol. 22 1570-1575
[8]
Reddy S(2012)Neoplasms of the appendix: current treatment guidelines Hematol Oncol Clin North Am. 26 1261-1290
[9]
Jorgensen TL(2015)Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: experience of a peritoneal surface malignancy center Am Surg. 81 1253-1259
[10]
Teiblum S(2016)Then and now: cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC), a historical perspective J Gastrointest Oncol. 7 18-28